(E)-2-((3S,5R)-3,5-Bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethan-1-ol

Catalog No. :
ACWJGU019
CAS No. :
227961-42-4
Molecular Formula :
C21H42O3Si2
Molecular Weight :
398.74

IUPAC Name:(E)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethan-1-ol

(E)-2-((3S,5R)-3,5-Bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethan-1-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$99.00Login to see priceInquiryInquiry
10mg98%$148.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-2-((3S,5R)-3,5-Bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethan-1-ol
IUPAC Name(E)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethan-1-ol
Molecular FormulaC21H42O3Si2
Molecular Weight398.74
SMILESOC/C=C1C([C@@H](O[Si](C)(C(C)(C)C)C)C[C@H](O[Si](C)(C(C)(C)C)C)C/1)=C
InChI KeyAPRWHRXRPYRYKF-FESWLXLESA-N
Synonym(E)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethan-1-ol;Ethanol, 2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]-, (2E)-
CAS No.227961-42-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACWJGU019 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWJGU019 route product structure diagram
    ACWJGU019227961-42-4
Inquiry

2. ACWJGU019 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWJGU019 route product structure diagram
    ACWJGU019227961-42-4
Inquiry

Comments (0)